| DRUG WATCH |
|
| Year : 2021 | Volume
: 53
| Issue : 6 | Page : 489-492 |
Nicolau syndrome following subcutaneous glatiramer acetate injection: A case report and review of the literature
Pelin Esme1, Irfan Gahramanov1, Egemen Akıncıoglu2, Gulsen Akoglu1
1 Department of Dermatology and Venereology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey
2 Department of Pathology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey
Correspondence Address:
Dr. Gulsen Akoglu
Department of Dermatology and Venereology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.ijp_166_21
Nicolau syndrome is a rare serious drug reaction associated with the administering various injectable medications. It is often characterized by an acute and severe pain accompanying erythema that tends to rapidly evolve into the livedoid reticular or hemorrhagic patches and less commonly to ulcers and skin necrosis. Herein, we report a 34-year-old woman who presented with painful, tender discoloration over her abdominal skin following subcutaneous glatiramer acetate injection. Since the patient was diagnosed with multiple sclerosis 18 months ago, she had been on treatment with subcutaneous glatiramer acetate injections thrice weekly. The patient was diagnosed with Nicolau syndrome clinically and histopathologically. After 15-day treatment with topical betamethasone valerate and mucopolysaccharide polysulfate cream twice daily, the lesion completely regressed with only minimal hypopigmented irregular scarring. Nicolau syndrome should be considered in patients with severe pain, tenderness, and redness localized at the injection site following glatiramer subacetate.
[FULL TEXT] [PDF]*
|
